MMEN Stock Overview
MedMen Enterprises Inc., together with its subsidiaries, operates as a cannabis retailer in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
MedMen Enterprises Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0 |
| 52 Week High | CA$0.05 |
| 52 Week Low | CA$0.015 |
| Beta | 1.42 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | n/a |
Recent News & Updates
Shareholder Returns
| MMEN | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | n/a | 8.8% | -0.5% |
| 1Y | n/a | 64.2% | 5.3% |
Return vs Industry: Insufficient data to determine how MMEN performed against the Canadian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how MMEN performed against the Canadian Market.
Price Volatility
| MMEN volatility | |
|---|---|
| MMEN Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 15.2% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CA Market | 18.1% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: MMEN has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MMEN's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 428 | n/a | www.medmen.com |
MedMen Enterprises Inc., together with its subsidiaries, operates as a cannabis retailer in the United States. The company provides products under the MedMen Red and LuxLyte brand names. As of June 25, 2022, it operated 19 stores in California, Nevada, Illinois, Arizona, and Massachusetts.
MedMen Enterprises Inc. Fundamentals Summary
| MMEN fundamental statistics | |
|---|---|
| Market cap | CA$23.81m |
| Earnings (TTM) | -CA$143.31m |
| Revenue (TTM) | CA$120.12m |
0.0x
P/S Ratio0.0x
P/E RatioIs MMEN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MMEN income statement (TTM) | |
|---|---|
| Revenue | US$120.12m |
| Cost of Revenue | US$63.44m |
| Gross Profit | US$56.68m |
| Other Expenses | US$199.99m |
| Earnings | -US$143.31m |
Last Reported Earnings
Mar 25, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.094 |
| Gross Margin | 47.18% |
| Net Profit Margin | -119.30% |
| Debt/Equity Ratio | -82.3% |
How did MMEN perform over the long term?
See historical performance and comparison